PMC:7172841 / 10183-10321 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T101","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"T102","span":{"begin":79,"end":82},"obj":"Disease"}],"attributes":[{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":83,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"}],"text":"Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001"}

{"project":"LitCovid-sentences","denotations":[{"id":"T82","span":{"begin":0,"end":138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":40,"end":60},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001"}

{"project":"LitCovid-PubTator","denotations":[{"id":"335","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A335","pred":"tao:has_database_id","subj":"335","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001"}